Literature DB >> 32718234

Assessing cardiovascular risk in cancer patients: opportunities and challenges.

Avirup Guha1,2, Nihar R Desai3,4, Neal L Weintraub5.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 32718234      PMCID： PMC8005777          DOI： 10.1177/2047487320943002

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  13 in total

1.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Guy De Backer; Marco Roffi; Victor Aboyans; Norbert Bachl; Héctor Bueno; Scipione Carerj; Leslie Cho; John Cox; Johan De Sutter; Günther Egidi; Miles Fisher; Donna Fitzsimons; Oscar H Franco; Maxime Guenoun; Catriona Jennings; Borut Jug; Paulus Kirchhof; Kornelia Kotseva; Gregory Y H Lip; François Mach; Giuseppe Mancia; Franz Martin Bermudo; Alessandro Mezzani; Alexander Niessner; Piotr Ponikowski; Bernhard Rauch; Lars Rydén; Adrienne Stauder; Guillaume Turc; Olov Wiklund; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur J Prev Cardiol       Date:  2016-06-27       Impact factor: 7.804

2.  Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry.

Authors:  José López-Sendón; Carlos Álvarez-Ortega; Pilar Zamora Auñon; Antonio Buño Soto; Alexander R Lyon; Dimitrios Farmakis; Daniela Cardinale; Miguel Canales Albendea; Jaime Feliu Batlle; Isabel Rodríguez Rodríguez; Olaia Rodríguez Fraga; Ainara Albaladejo; Guiomar Mediavilla; Jose Ramón González-Juanatey; Amparo Martínez Monzonis; Pilar Gómez Prieto; José González-Costello; José María Serrano Antolín; Rosalía Cadenas Chamorro; Teresa López Fernández
Journal:  Eur Heart J       Date:  2020-05-07       Impact factor: 29.983

3.  The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients.

Authors:  Daniel Lapirow; Andre La Gerche; Claudia Toro; Emma Masango; Ben Costello; Enzo Porello; Louise Ludlow; Glenn Marshall; Toby Trahair; Marion Mateos; Jeremy Lewin; Jennifer Byrne; Rose Boutros; Rebecca Manudhane; John Heath; Julian Ayer; Melissa Gabriel; Thomas Walwyn; Jelena Saundankar; Jonathon Forsey; Ha Le; Kylie Mason; David Celermajer; Peter Downie; Roderick Walker; Lucy Holland; Michelle Martin; Lorna McLeman; Yonatan Diamond; Maurizio Marcocci; Susan Donath; Michael Cheung; David A Elliott; Rachel Conyers
Journal:  Intern Med J       Date:  2021-02       Impact factor: 2.048

4.  Effects of a health screening on mortality and causes of death in middle-aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914.

Authors:  O Lannerstad; N H Sternby; S O Isacsson; G Lindgren; S E Lindell
Journal:  Scand J Soc Med       Date:  1977

Review 5.  Decline in Cardiovascular Mortality: Possible Causes and Implications.

Authors:  George A Mensah; Gina S Wei; Paul D Sorlie; Lawrence J Fine; Yves Rosenberg; Peter G Kaufmann; Michael E Mussolino; Lucy L Hsu; Ebyan Addou; Michael M Engelgau; David Gordon
Journal:  Circ Res       Date:  2017-01-20       Impact factor: 17.367

6.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

7.  NCCN Guidelines Insights: Survivorship, Version 2.2019.

Authors:  Tara Sanft; Crystal S Denlinger; Saro Armenian; K Scott Baker; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Divya Koura; Robin M Lally; Terry S Langbaum; Allison L McDonough; Michelle Melisko; Kathi Mooney; Halle C F Moore; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Lindsay Peterson; William Pirl; M Alma Rodriguez; Kathryn J Ruddy; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2019-07-01       Impact factor: 11.908

8.  Community surveillance for coronary heart disease: the Framingham Cardiovascular Disease Survey. Methods and preliminary results.

Authors:  J R Margolis; R F Gillum; M Feinleib; R C Brasch; R R Fabsitz
Journal:  Am J Epidemiol       Date:  1974-12       Impact factor: 4.897

9.  Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry.

Authors:  Juan Caro-Codón; Teresa López-Fernández; Carlos Álvarez-Ortega; Pilar Zamora Auñón; Isabel Rodríguez Rodríguez; Pilar Gómez Prieto; Antonio Buño Soto; Miguel Canales Albendea; Ainara Albaladejo; Guiomar Mediavilla; Jaime Feliu Batlle; Olaia Rodríguez Fraga; Amparo Martínez Monzonis; José González-Costello; José María Serrano Antolín; Rosalía Cadenas Chamorro; José R González-Juanatey; José López-Sendón
Journal:  Eur J Prev Cardiol       Date:  2022-05-06       Impact factor: 7.804
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.